###begin article-title 0
###xml 74 79 <span type="species:ncbi:9606">Human</span>
Characterization of a Lipoyl Domain-independent B-cell Autoepitope on the Human Branched-chain Acyltransferase in Primary Biliary Cirrhosis and Overlap Syndrome with Autoimmune Hepatitis
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 19 0 19 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">Background and aims</italic>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
###xml 335 341 <span type="species:ncbi:9913">bovine</span>
Background and aims: Antimitochondrial antibodies (AMA) which recognize pyruvate acetyltransferase (PDC-E2) represent a highly diagnostic feature of primary biliary cirrhosis (PBC). The analysis of immunofluorescence (IF)-AMA-positive sera in PBC patients indicates a conformational epitope located within the lipoyl binding domain of bovine branched-chain acyltransferase (BCKADC-E2) alone or in combination with AMA directed against PDC-E2 the significance of which is presently unclear. In the present study, immunoreactivities and disease associations of AMA against BCKADC-E2 were analyzed. B-cell autoepitopes on BCKADC-E2 were mapped by immunoprecipitation assay.
###end p 2
###begin p 3
###xml 0 7 0 7 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 96 97 96 97 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 122 123 122 123 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 170 171 170 171 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 308 316 308 316 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 407 408 407 408 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 436 437 436 437 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 471 472 471 472 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 519 520 519 520 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
Methods: Sera of 96 IF-AMA-positive patients with serological evidence of anti-BCKADC-E2 alone (n=26), anti-PDC-E2 alone (n=15), and both anti-BCKADC-E2 and anti-PDC-E2 (n=55) were analyzed by Western blot and ELISA in addition to an analysis of B cell autoepitopes on BCKADC-E2 by immunoprecipitation using in vitro translated, unmodified human proteins. Ninety-four patients without IF-AMA [blood donors (n=30), rheumatoid arthritis (n=40), autoimmune hepatitis (AIH) (n=10) and primary sclerosing cholangitis (PSC) (n=14] served as controls.
###end p 3
###begin p 4
###xml 0 7 0 7 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
Results: Eighty of 81 (99%) sera positive for BCKADC-E2 recognized the full length, mature protein, while only 2/10 AIH sera and none of the other controls showed reactivity. Of the 68 PBC sera 58 (85%) recognized the N-terminus consisting of aa 1-144 representing the lipoyl domain. Surprisingly, C-terminal sequences (aa 143-421) were recognized by 46 out of 68 sera (68%). Three PBC sera reacted with the C-terminus only. Only 1/7 serum from patients with an "overlap syndrome of PBC and AIH" was reactive with C-terminal sequences.
###end p 4
###begin p 5
###xml 0 11 0 11 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions</italic>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 370 378 <span type="species:ncbi:9606">patients</span>
Conclusions: Our analysis of BCKADC-E2-positive PBC sera identified a novel B cell epitope on the C-terminal part of the human protein. Our data indicate that a distinct subset of AMA recognize sequence(s) on BCKADC-E2 which located outside of the lipoyl binding domain. The absence of immunoreactivity against C-terminal sequences may serve as a marker differentiating patients with PBC and overlap syndrome of PBC with AIH.
###end p 5

